MedTrace Logo

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)

NCT04167267 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-11-22

No results posted yet for this study

Summary

This is a randomized, open-label, single dose study to evaluate the safety and pharmacokinetics of DWP14012 tablet A and DWP14012 tablet B in healthy volunteers

Conditions

  • Healthy

Interventions

DRUG

DWP14012 tablet A

Period 1: DWP14012 tablet B Period 2: DWP14012 tablet A

DRUG

DWP14012 tablet B

Period 1: DWP14012 tablet A Period 2: DWP14012 tablet B

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167267 on ClinicalTrials.gov